Drug Profile
Cefaclor sustained release - Beijing CoSci Med Tech
Latest Information Update: 31 Oct 2021
Price :
$50
*
At a glance
- Originator Beijing CoSci Med-Tech
- Class Antibacterials; Cephalosporins
- Mechanism of Action Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase Unknown Pharyngitis; Respiratory tract infections; Skin and soft tissue infections; Tonsillitis; Urinary tract infections
Most Recent Events
- 27 Jul 2016 Chemical structure information added
- 26 Jul 2016 Investigation in Pharyngitis in China (PO)
- 26 Jul 2016 Investigation in Respiratory tract infections in China (PO)